Drug Trial Radar · NCT03809429
Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND)
Last checked: Nov 19, 2026Latest source record: May 13, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
437
Actual
Start
Apr 29, 2019
Primary completion
Feb 16, 2022
Study completion Feb 16, 2022
Sponsor
- Lead sponsor
- Ferring PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Jan 18, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years, up to 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To compare the efficacy and safety of FE 999049 (follitropin delta) and its personalized dosing algorithm in controlled ovarian stimulation for in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) using a long gonadotropin-releasing hormone (GnRH) agonist protocol versus a short GnRH antagonist protocol.
Conditions
- Infertility, Female
Interventions
FE 999049 + GnRH agonist (GONAPEPTYL)Drug
Pre-filled injection pen
FE 999049 + GnRH antagonist (CETROTIDE)Drug
Powder and solvent for solution for injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Oocytes RetrievedTime frame: On day of oocyte retrieval (up to 22 days after start of stimulation)
Locations
16 sites in 7 countries. Site status is shown where the registry gives one.
Das Kinderwunsch Institut Schenk GmbH
Dobl, Austria
Kepler University Hospital Linz
Linz, Austria
Kinderwunschzentrum Goldenes Kreuz Privatklinik
Vienna, Austria
Rigshospitalet
Copenhagen, Denmark
Hillel Yafe Medical Center
Hadera, Israel
Shaare Zedek Medical Center
Jerusalem, Israel
Beilinson Hospital Rabin Medical Center
Petah Tikva, Israel
Sourasky Medical Center
Tel Aviv, Israel
Dipartimento della Donna, del bambino e delle malattie urologiche
Bologna, Italy
European Hospital
Roma, Italy
St. Elisabeth Ziekenhuis
Tilburg, Netherlands
Isala Fertility Center
Zwolle, Netherlands
Oslo University Hospital
Oslo, Norway
Sykehuset Telemark HF
Porsgrunn, Norway
Medicus AS
Trondheim, Norway
Gyn-A.R.T. AG
Zurich, Switzerland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.